MARKETSNatco Pharma Approves Rs 1,279 Crore Rights IssueTabassum ChaudharySeptember 25, 2026September 25, 2026 September 25, 2026September 25, 2026 Natco Pharma shares touched a day high of Rs 850.10 on Friday, after the board approved a Rs 1,279 crore rights issue to raise funds....
BUSINESSEPL Eyes Rs 20,000 Cr Revenue in 5 Years via Indovida MergerTabassum ChaudharySeptember 18, 2026September 18, 2026 September 18, 2026September 18, 2026 EPL Limited aims to double its revenue to Rs 20,000 crore over five years, anchored by its pending merger with Indovida. EPL’s Managing Director and...